Fresenius Acquires Akorn and Scoops Biosimilar Portfolio from Merck KGaA
By Jawala Prasad
Pharma Deals Review: Vol 2017 Issue 5 (Table of Contents)
Published: 20 May-2017
DOI: 10.3833/pdr.v2017.i5.2246 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to strengthen its medicines arm, Fresenius Kabi announced two deals on the same day - the acquisition of Akorn, a sterile injectables specialist in a deal worth US$4...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS